HRP20010083B1 - A process for the preparation of zofenopril calcium salt - Google Patents

A process for the preparation of zofenopril calcium salt

Info

Publication number
HRP20010083B1
HRP20010083B1 HR20010083A HRP20010083A HRP20010083B1 HR P20010083 B1 HRP20010083 B1 HR P20010083B1 HR 20010083 A HR20010083 A HR 20010083A HR P20010083 A HRP20010083 A HR P20010083A HR P20010083 B1 HRP20010083 B1 HR P20010083B1
Authority
HR
Croatia
Prior art keywords
zofenopril
salt
calcium salt
preparation
potassium salt
Prior art date
Application number
HR20010083A
Other languages
English (en)
Inventor
Pok. Giorgi Raffaello
Original Assignee
Menarini International Operations Luxembourg S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A. filed Critical Menarini International Operations Luxembourg S.A.
Publication of HRP20010083A2 publication Critical patent/HRP20010083A2/hr
Publication of HRP20010083B1 publication Critical patent/HRP20010083B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00Compounds of calcium, strontium, or barium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Geology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20010083A 1998-08-04 2001-02-01 A process for the preparation of zofenopril calcium salt HRP20010083B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI001833A IT1301993B1 (it) 1998-08-04 1998-08-04 Processo per la preparazione di zofenopril sale di calcio.
PCT/EP1999/005461 WO2000007984A1 (en) 1998-08-04 1999-07-30 A process for the preparation of zofenopril calcium salt

Publications (2)

Publication Number Publication Date
HRP20010083A2 HRP20010083A2 (en) 2002-02-28
HRP20010083B1 true HRP20010083B1 (en) 2005-02-28

Family

ID=11380611

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010083A HRP20010083B1 (en) 1998-08-04 2001-02-01 A process for the preparation of zofenopril calcium salt

Country Status (32)

Country Link
US (2) US6521760B1 (xx)
EP (1) EP1102745B1 (xx)
JP (1) JP2002522417A (xx)
KR (1) KR100593428B1 (xx)
CN (1) CN1146538C (xx)
AT (1) ATE266635T1 (xx)
AU (1) AU5372299A (xx)
BG (1) BG65022B1 (xx)
BR (1) BR9912842A (xx)
CA (1) CA2339283C (xx)
CU (1) CU23171A3 (xx)
CZ (1) CZ301908B6 (xx)
DE (1) DE69917282T2 (xx)
DK (1) DK1102745T3 (xx)
EA (1) EA003454B1 (xx)
EE (1) EE04798B1 (xx)
ES (1) ES2221417T3 (xx)
HK (1) HK1039616B (xx)
HR (1) HRP20010083B1 (xx)
HU (1) HU227557B1 (xx)
IL (1) IL141222A0 (xx)
IT (1) IT1301993B1 (xx)
NO (1) NO319773B1 (xx)
PL (1) PL193828B1 (xx)
PT (1) PT1102745E (xx)
RS (1) RS49768B (xx)
SI (1) SI1102745T1 (xx)
SK (1) SK285527B6 (xx)
TR (1) TR200100272T2 (xx)
UA (1) UA65628C2 (xx)
WO (1) WO2000007984A1 (xx)
ZA (1) ZA200100907B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2560502T3 (es) * 2005-07-01 2016-02-19 Generics [Uk] Limited Zofenopril calcio en forma de polimorfo C
EA012845B1 (ru) * 2005-12-09 2009-12-30 Менарини Интернэшнл Оперейшнс Люксембург С. А. Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии
SI2041083T1 (sl) * 2006-05-26 2015-02-27 Generics (Uk) Limited Metode za pripravo zofenopril kalcija
GB0715626D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Crystalline form of zofenopril calcium
AU2009219892B2 (en) * 2008-02-27 2014-08-07 Generics [Uk] Limited Novel crystalline forms
US8853421B2 (en) 2008-02-27 2014-10-07 Generics [Uk] Limited Crystalline forms of zofenopril calcium
EP2389360A4 (en) * 2009-01-23 2013-01-16 Glenmark Generics Ltd METHOD FOR PRODUCING ZOFENOPRIL AND PHARMACEUTICAL ACCEPTIC SALTS THEREFOR
SI23949A (sl) 2011-12-19 2013-06-28 Silverstone Pharma Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji
CN104138359B (zh) * 2013-05-06 2016-03-02 扬子江药业集团上海海尼药业有限公司 佐芬普利钙片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) * 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4154935A (en) * 1978-02-21 1979-05-15 E. R. Squibb & Sons, Inc. Halogen substituted mercaptoacylamino acids
US4316906A (en) * 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines

Also Published As

Publication number Publication date
HK1039616A1 (en) 2002-05-03
HUP0103826A2 (hu) 2002-02-28
SK1632001A3 (en) 2001-09-11
SI1102745T1 (en) 2004-10-31
EA200100095A1 (ru) 2001-08-27
CZ2001408A3 (cs) 2001-07-11
DE69917282T2 (de) 2005-05-25
CN1316992A (zh) 2001-10-10
YU7501A (sh) 2005-06-10
HUP0103826A3 (en) 2002-03-28
ITMI981833A0 (it) 1998-08-04
KR100593428B1 (ko) 2006-06-28
ITMI981833A1 (it) 2000-02-04
ES2221417T3 (es) 2004-12-16
EP1102745A1 (en) 2001-05-30
US6521760B1 (en) 2003-02-18
NO20010552L (no) 2001-02-01
HK1039616B (zh) 2004-10-08
IT1301993B1 (it) 2000-07-20
CU23171A3 (es) 2006-09-22
UA65628C2 (uk) 2004-04-15
US20020156293A1 (en) 2002-10-24
WO2000007984A1 (en) 2000-02-17
HU227557B1 (en) 2011-08-29
NO319773B1 (no) 2005-09-12
ATE266635T1 (de) 2004-05-15
DE69917282D1 (de) 2004-06-17
ZA200100907B (en) 2001-10-04
CN1146538C (zh) 2004-04-21
CA2339283C (en) 2009-03-17
BG105176A (en) 2001-11-30
KR20010072171A (ko) 2001-07-31
TR200100272T2 (tr) 2001-05-21
PL193828B1 (pl) 2007-03-30
EE04798B1 (et) 2007-04-16
PT1102745E (pt) 2004-08-31
EA003454B1 (ru) 2003-06-26
BR9912842A (pt) 2001-10-16
CA2339283A1 (en) 2000-02-17
AU5372299A (en) 2000-02-28
DK1102745T3 (da) 2004-08-02
RS49768B (sr) 2008-06-05
CZ301908B6 (cs) 2010-07-28
EE200100065A (et) 2002-06-17
SK285527B6 (sk) 2007-03-01
JP2002522417A (ja) 2002-07-23
PL345814A1 (en) 2002-01-14
EP1102745B1 (en) 2004-05-12
IL141222A0 (en) 2002-03-10
US6515012B2 (en) 2003-02-04
NO20010552D0 (no) 2001-02-01
HRP20010083A2 (en) 2002-02-28
BG65022B1 (bg) 2006-12-29

Similar Documents

Publication Publication Date Title
BR0308385A (pt) Cristais de ácido (met) acrìlico e processo para produzir e purificar ácido (met) acrìlico aquoso
CA2473900A1 (en) A process for recovery of low sodium salt from bittern
HK1039616A1 (en) A process for the preparation of zofenopril calcium salt
GB2437006A (en) Salts assisted selective extraction of 6-acetyl-4.1',6'trichlorogalactosucrose and 4,1',6'trichlorogalactosucrose from aqueous reaction mixture
CA2425615A1 (en) Process for the purification of gabapentin using a strong cation exchange resin
CA2244948A1 (en) Waste stream treatment
MY112976A (en) Process for purifying valine
HRP20020887B1 (en) Method for synthesis of n-[(s)-1-carboxybutyl]-(s)-alanine esters and use in synthesis of perindopril
EA200501734A1 (ru) Способ получения (4-гидрокси-6-оксотетрагидропиран-2-ил)ацетонитрила и его производных
AU8182701A (en) Method for producing 5-aminosalicyclic acid
MXPA04005788A (es) Proceso para preparacion de derivados de [1,4,5]-oxadiazepina.
HRP20000749B1 (en) Purification of carboxaldehyde
WO2004087939A8 (en) A process for the preparation of fludarabine phosphate from 2-fluoroadenine and fludarabine phosphate salts with amines or ammonia
White et al. Labeling of amide linkages in active site mapping: Carbonium ion and extended photoaffinity labeling approaches
FI982076A (fi) Menetelmä kaliumformiaatin valmistamiseksi
CO5560549A2 (es) Proceso para recuperar caprolactama a partir de un producto de caprolactama acuoso, utilizando un caproato amino alcali preparado in situ
KR960004365A (ko) 5'-리보뉴클레오티드칼슘의 제조방법
WO2002044155A8 (de) Verfahren zur herstellung von phenylen-bis-benzimidazol-tetrasulfonsäure-dinatriumsalz
FR2791682B1 (fr) Procede de preparation du 4'-demethyl-4'-phosphate-2", 3"-bis pentafluorophenoxyacetyl-4",6"-ethyldidene-beta-d- glucoside d'epipodophyllotoxine, et de ses sels
RO113970B1 (ro) Procedeu de obţinere a iodurii de potasiu de calitate reactiv
WO2007016209A3 (en) Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process
FR2816308B1 (fr) Procede de production en continu d'un sel concentre d'acide succinique
RO93320B1 (ro) Procedeu de preparare a 5,5-dimetilhidantoinei
MX2007008617A (es) Preparacion de lactamas.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.,

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20180627

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20190730